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132a Sunday, February 8, 2015novel genetically modified mouse line expressing the r/hM3Dq DREADD
under the control of an MCK promotor allowed specific Gq activation by
the design drug CNO. 5 mM CNO (blood plasma concentration) induced
massive cardiac arrhythmias (sinus arrest, AV-blocks, tachycardia and
deformed QRS complexes) within minutes after injection only in r/hM3Dq
expressing mice. Isolated hearts and experiments on ventricular and atrial
myocytes supported such in-vivo findings. From these data we conclude
that Gq-coupled signaling exerts genomic and non-genomic changes on the
heart well exceeding the purely InsP3 dependent signaling and thus offers
novel insights in cardiac rhythm generation and propagation in health and
disease.
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Novel functional analyses and numerical models have led to a paradigm shift in
sinoatrial nodal pacemaker cell biology. Recent reports of transcriptional pro-
files of SAN, however, have focused on a limited number of pre-selected tran-
scripts, while the large-scale transcriptome profile of SAN pacemaker cells
remains unknown. Using Illumina Ref8v2 bead chips we performed large-
scale transcriptome analysis of sinoatrial node (SAN) and compared it to those
of left and right atrium (LA and RA), left and right ventricle (LV and RV) and
spontaneously beating cultured HL-1 cells.
Principal component analysis of transcriptomic relationship among samples
revealed a distinct supraventricular grouping (LA, RA, SAN and HL-1), a
ventricular grouping (LV, RV), a native heart tissue grouping, (LA, RA,
SAN, LV and RV) and the cultured cell line. Overexpressed genes specific
to each native heart tissue (greater than 75th percentile for that group)
were 3946 transcripts evenly expressed among its component tissues. The
supraventricular group expression of 87 of these genes was specifically en-
riched in SAN; 95, in RA and 205 in LA; ventricular grouping embraced
2773 common transcripts, with 901 transcripts being enriched in LV and
142 in RV. Some findings in SAN compare to other heart tissues, for
example, PDE1A, Tbx3, RGS4, ISL1, were highly overexpressed. The co-
expression gene networks by the weighted gene co-expression analysis reveal
that neuron projection, fatty acid metabolic process, neuron differentiation
and response to endogenous stimulus pathways were highly represented in
SAN.
In summary, this is the first large-scale transcriptomic analysis of cardiac pace-
maker tissue and its comparison to other cardiac tissue. Novel gene markers for
SAN were observed. The results provide valuable clues with respect to regen-
eration of SAN-like beating cells from pluripotent cell lines and to the design of
biological pacemakers.
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Introduction: Recently, genome wide association studies (GWAS) identified
LITAF (lipopolysaccharide-induced TNF factor) as one of the novel loci
associated with prolongation of QT interval. Our goal is to investigate the
role of LITAF in regulating cardiomyocyte excitability and action potential
duration (APD). Methods: Optical mapping was performed in zebrafish hearts
to determine Ca2þ transients and transmembrane (TM) potentials. Propagation
velocities of depolarizing waves were determined. Action potential (AP) was
digitally imaged in adenoviral infected neonatal rabbit cardiomyocytes
(NRbCM). Live cell confocal calcium imaging was performed on adult rabbit
ventricular myocytes (ARbCM) to determine intracellular Ca2þ handling. A
current-voltage (I-V) relationship for the L-type calcium current (ICa,L ) was
determined using whole cell patch clamping. To study the effect of LITAF
on Cav1.2 channel expression, surface biotinylation and western blot assays
were performed using tSA201 cells. Results: Our studies demonstrate that
loss-of-function of LITAF in vivo (zebrafish) increases the Ca2þ transient
amplitude (which primarily depends on calcium influx), slows atrial-
ventricular conduction, and prolongs the APD. In contrast, in vitro gain-of-
function experiments in rabbit CM established that overexpression of LITAF
downregulates the total and surface pools of Cav1.2 channel polypeptides, de-
creases Ca2þ transients and L-type Ca2þ conductance, and shorten the APD.
Studies in heterologous expression systems revealed that one of the auxiliary
subunits of Cav1.2 channels, Cavb2b, is likely involved in LITAF-mediatedinhibition of recombinant Cav1.2 channels. Conclusion: LITAF regulates the
expression and function of Cav1.2 channels, thereby determining APD and car-
diac cell excitation.
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Mitochondria exchange matrix content in a unique and dynamic way by one
of two mechanisms: a short-range direct interaction via closely spaced
kissing junctions or long-range propagation of signal by the extrusion of
extended nanotubular extensions (nanotunneling) (Huang et al 2013. Proc
Natl Acad Sci U S A, 110(8): 2846-51). Both are normal, but infrequent fea-
tures of cardiac myocytes. It is interesting to know whether this behavior
may be affected by changes in Ca2þ homeostasis. We evaluated the cardiac
ultrastructure in 7-month old heterozygous mice with a cardiac ryanodine
receptor (RyR2) mutation (RyR2-A4860G) that depresses channel function
and leads to Catecholaminergic Polymorphic Ventricular Tachycardia
(CPVT) without hypertrophy (Zhao et al., submitted). The mutation is em-
bryonic lethal in mice homozygous for the mutation. In ventricular myocytes
of heterozygotes mice (RyR2-A4860Gþ/) it has a dual effect on SR Ca2þ
release: an initial reduction due to lower RyR2 activity, linked to random
bursts due to SR Ca2þ overload. The most striking and only structural alter-
ation in cardiac myocytes in the mutant left ventricle is a clear increase in
the frequency of long thin nano-tunneling mitochondrial extensions. The fre-
quency of nanotunneling was ~3 fold higher in mutant than in WT mice.
Numerous small mitochondrial profiles are more frequent in mutant mice
resulting in an average surface area of 0.175 0.15 mm2 in mutant versus
0.28 5 0.22 mm2 in WT (p<0.00001). This decrease is mostly due to sec-
tions through the thin tunneling extensions. The increased nanotunneling fre-
quency would indicate an enhanced rate of long range intermitochondrial
signal transfer. Interestingly, no activation of nanotunneling has been re-
ported by EM in other CPVT models and/or in other alterations affecting
proteins of CRU and Ca2þ homeostasis, making this a unique mitochondrial
response.
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Background: Wnt signaling plays crucial roles in heart development but is nor-
mally suppressed postnatally. In arrhythmogenic conditions, such as cardiac
hypertrophy and heart failure, Wnt signaling is reactivated. We explored the
potential role of Wnt signaling in arrhythmogenic electrical remodeling by
examining ion channel changes in postnatal cardiomyocytes with activated
Wnt signaling.
Methods:Neonatal rat ventricular myocytes (NRVMs) were treated with either
recombinant Wnt3a protein (0.1-1.0 mg/ml) or CHIR-99021 (CH, 3 mM,
a glycogen synthase kinase-3b inhibitor) to activate canonical Wnt signaling.
Gene expression was assayed by real-time RT-PCR.Western blot and immuno-
cytostaining were used to investigate protein changes. Ionic currents were re-
corded using whole-cell patch-clamp.
Results: Treatment of NRVMs with either Wnt3a or CH caused a dose-
dependent increase in Wnt target gene expression (Axin2 and Lef1), indicating
activation of the Wnt/b-catenin pathway. Cardiac Naþ current (INa) density was
reduced (p<0.01, n>10) by Wnt3a (2054 vs. control5957 pA/pF, at30
mV) or CH (2255 pA/pF), without changes in steady-state inactivation or
repriming kinetics. Wnt3a and CH also produced dose-dependent reductions
in the mRNA level of Scn5a (the cardiac Naþ channel a subunit gene), as
well as a 60% reduction in Nav1.5 protein level. Consistent with INa reduction,
action potentials in Wnt3a-treated NRVMs had lower (p<0.01, n¼5) upstroke
amplitude (9153 vs. control 13752 mV) and decreased maximum upstroke
velocity (70510 vs. control 163515 V/s). In contrast, inward rectifier Kþ cur-
rent and L-type Ca2þ current were not affected by Wnt3a treatment (n¼8).
Conclusions: The Wnt/b-catenin pathway selectively suppresses INa expres-
sion in postnatal cardiomyocytes and may contribute to arrhythmogenic remod-
eling in heart failure. Thus, the Wnt/b-catenin pathway may be a novel
therapeutic target for heart failure and cardiac arrhythmias.
